Mersana Therapeutics, Inc. (MRSN) has a consensus analyst rating of Buy, based on 19 analysts covering the stock. Of those, 11 recommend buying, 8 recommend holding, and 0 recommend selling.
The analyst consensus price target for MRSN is $3.00, representing a -89.7% downside from the current price of $29.08. Price targets range from a low of $3.00 to a high of $3.00.
